http://www.bioregio-stern.de/en/news-press/press-releases (19.06.2013)
Pressemitteilungen
Title |
Content | Date |
|---|---|---|
| REGiNA speeds up the development and introduction of innovative forms of therapy | The German Federal Minister of Education and Research , Dr. | 05.06.2008 |
| Reorganisation of Supervisory Board | The Supervisory Board will continue to be fully committed to BioRegio STERN Management GmbH successfully promoting biotechnology companies in the Stuttgart and Neckar-Alb regions and in the cities | 05.02.2010 |
| Reutlingen spin-off offers innovative service – a tick testing kit for use by non-professionals | scarabaeus gmbH & co. kg, based in Reutlingen in the STERN BioRegion, develops and markets easy-to-use testing kits for the detection of Borrelia bacteria, avian influenza and influenza A. | 04.08.2006 |
| SAP founder Dietmar Hopp invests in Tübingen biotech company | CureVac GmbH, a Tübingen-based biopharmaceutical company focusing on the development of drugs to combat cancer, has completed its second round of financing. | 18.01.2006 |
| Scientific achievements provide economic driving force | The Natural and Medical Science Institute (NMI) at the University of Tübingen, which has enjoyed 20 years of international success, combines a thirst for scientific research with business expertise | 01.07.2005 |
| Self-financing through combination of research and service | Synovo and Bone Medical will work together to develop preparations for treating bone diseases such as osteoporosis and arthritis. | 12.05.2006 |
| Semantic technologies enable future-focused knowledge management | Entrepreneurs looking to secure lasting competitiveness need to adapt to the vast changes which make today’s business world less industrial and more involved with information and data processing. | 28.10.2009 |
| Sensational results in stem cell research | Prof. Dr. Thomas Skutella has succeeded in obtaining pluripotent human stem cells from testicles. | 10.10.2008 |
| Signing to Become the Global Market Leader | Tübingen-based Hölle & Hüttner AG is taking over the entire share capital of Cologne-based INTAVIS Bioanalytical Instruments AG retroactively as of 1 January 2008. | 17.07.2008 |
| Skin transplants: Excellent conditions for research and production | euroderm GmbH has entered into an equity investment with Buck-Chemie GmbH of Herrenberg within the framework of the Enterprise Resource Planning (ERP) start-up fund and is receiving Euro 1 million | 09.08.2006 |